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Background: Infections caused by canine parvovirus, canine distemper virus and canine coronavirus are an
important cause of mortality and morbidity in dogs worldwide. Prior to this study, no information was available
concerning the incidence and prevalence of these viruses in Cape Verde archipelago.
Results: To provide information regarding the health status of the canine population in Vila do Maio, Maio Island,
Cape Verde, 53 rectal swabs were collected from 53 stray dogs during 2010 and 93 rectal swabs and 88 blood
samples were collected from 125 stray dogs in 2011. All rectal swabs (2010 n = 53; 2011 n = 93) were analysed for
the presence of canine parvovirus, canine distemper virus and canine coronavirus nucleic acids by quantitative PCR
methods. Specific antibodies against canine distemper virus and canine parvovirus were also assessed (2011 n = 88).
From the 2010 sampling, 43.3% (23/53) were positive for canine parvovirus DNA, 11.3% (6/53) for canine distemper
virus RNA and 1.9% (1/53) for canine coronavirus RNA. In 2011, the prevalence values for canine parvovirus and
canine coronavirus were quite similar to those from the previous year, respectively 44.1% (41/93), and 1.1% (1/93),
but canine distemper virus was not detected in any of the samples analysed (0%, 0/93). Antibodies against canine
parvovirus were detected in 71.6% (63/88) blood samples and the seroprevalence found for canine distemper virus
was 51.1% (45/88).
Conclusions: This study discloses the data obtained in a molecular and serological epidemiological surveillance
carried out in urban populations of stray and domestic animals. Virus transmission and spreading occurs easily in
large dog populations leading to high mortality rates particularly in unvaccinated susceptible animals. In addition,
these animals can act as disease reservoirs for wild animal populations by occasional contact. Identification of
susceptible wildlife of Maio Island is of upmost importance to evaluate the risk of pathogen spill over from
domestic to wild animals in Cape Verde and to evaluate the associated threat to the wild susceptible species.
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Over the past few years, efforts have been made towards
a better understanding of the health status of animal
populations, particularly regarding viral infections. Due
to their high mutation rate and replication strategies, vi-
ruses are responsible for recently recognized emerging
diseases, posing a danger not only to domestic and wild
animals, but also to humans [1,2].* Correspondence: anaduarte@fmv.utl.pt
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distribution, and reproduction in any mediumThe high density of domestic and stray animals in urban
areas enables viral dissemination and maintenance in these
populations. Consequently, these animals can act as reser-
voirs of diseases, with the possibility of transmission to
wildlife populations through occasional contact.
Canine parvovirus (CPV) was first identified in the
late 1970s and was responsible for severe hemorrhagic
gastroenteritis and myocarditis in dogs [3]. Parvovi-
ruses are extremely stable in the environment and in-
direct transmission assumes a critical role in spreadingntral Ltd. This is an Open Access article distributed under the terms of the
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especially in wild carnivores, in which contact rates
between animals are lower [4]. Shortly after its initial
detection, CPV-2 was replaced by two antigenic vari-
ants, CPV-2a and CPV-2b and more recently a third
variant was described CPV-2c [5,6].
Canine distemper virus (CDV) is the etiological
agent of canine distemper, a highly contagious disease,
responsible for high mortality rates in dogs worldwide.
Sequence analysis of CDV strains originated in differ-
ent geographical areas from several animal species,
showed that the hemagglutinin gene has undergone a gen-
etic drift according to the geographic location [7,8]. Phylo-
genetic analysis based on this gene revealed the existence
of at least nine strains in different geographical areas,
namely America-1, America-2, Asia-1, Asia-2, Europe-1/
South America 1, European wildlife, Arctic-like, South
America 2 and Southern Africa [9,10].
Canine coronavirus (CCoV) causes a mild to moderate
enteritis in dogs and its infection is characterized by
high morbidity and low mortality. CCoV is transmitted
by faecal-oral route and spreads rapidly through a group
of susceptible animals [11]. Stressful environments with
large concentrations of animals and poor hygienic condi-
tions, often seen in kennels, favour the development of
this disease [12]. Although a higher mortality rate is ob-
served in animals with multiple infections with other
pathogens such as CPV-2, canine adenovirus type 1 and
CDV, CCoV represents per si a major infectious agent
responsible for several epidemics [13,14].
Virological surveys are conducted throughout the
world, allowing the detection and analysis of a large var-
iety of viruses in different animal populations. In Cape
Verde archipelago to our knowledge, no similar study
had been conducted so far. In order to detect the pres-
ence of canine viruses on Maio island, samples collected
from stray dogs from Vila do Maio were tested for ca-
nine parvovirus (CPV), canine distemper virus (CDV)
and canine coronavirus (CCoV), to estimate the viral
prevalence in this population and investigate the role of
these animals in the maintenance and potential spread
of common viral pathogens.Table 1 Results of viral nucleic acid investigation in each
year (Number of positive samples/total of samples analyzed
2010 2011
CPV DNA 23/53 (43,3%) 41/93 (44,1%)
CDV RNA 6/53 (11,3%) 0/93 (0%)
CcoV RNA 1/53 (1,9%) 1/93 (1,1%)
The percentage of positivity in each group is indicated between brackets.Results
Records were only available for the specimens sampled
in 2011. Of the 125 dogs, all them of undetermined or
mixed breeds, 65 were females (52%) and 57 males
(46%). For 3 dogs (2%) no data was registered regarding
gender.
Diaharreic feaces were described for 4 animals (3%).
Only two dogs had been vaccinated, both with Tetradog®
vaccine and no information regarding vaccination of the
rest of the animals was available (NA).The percentage of positivity for CPV-DNA was very
similar in the 2010 and 2011 sampling; 23/53 (43.3%)
and 41/93 (44.1%, respectively). From the 88 sera sam-
pling collected during 2011, 63 (71.6%) tested positive
for CPV antibodies, with 10 animals included in the first
ELISA Unit (EU) class (100–1000 EU), 29 in the second
EU class (1000–10000 EU) and 24 in the third EU class
(>10000 EU) (Tables 1 and 2).
Antibodies against CPV were detected in 20% of the
animals aged less than 6 months (2/10), in 57.1% in dogs
aged between 6 months and 1 year (8/14), in 87.5% in
dogs with 1 to 2 years (14/16), in 85.3% in dogs with 2
to 5 years (29/34), in 75% in dogs with 5 to 7 years (6/8)
and in 1/1 dog older than 7 years (Figure 1). The pro-
portion of seropositive animals was significantly higher
in older animals (p < 0.05). No differences were found
between the seroprevalence and gender (p > 0.05). From
the 56 samples that were tested for virology and ser-
ology, 46.6% (26/56) were positive for CPV-DNA and
64.3% (36/56) were seropositive. Out of the 26 dogs that
were excreting the virus at the time of collection, 7 were
seronegative for CPV specific IgG.
Regarding the 2010 samples tested for CDV-RNA (n =
53), 6 animals were positive (11.3%), of which 2 were also
co-infected with CPV. All samples from 2011 were found
CDV-RNA negative. As for serology, 45 of the 88 animals
sampled during 2011 were seropositive for CDV (51.1%).
Two groups were identified according to the antibody (Ab)
titer: 1) low Ab titer (IIF values 1/20-1/40: n = 43 (96%));
and 2) medium Ab titer (IIF values 1/80-1/160: n = 2 (4%)).
Antibodies against CDV were detected in 30% of ani-
mals aged less than 6 months (3/10), in 50% of dogs
aged between 6 months and 1 year (7/14), in 56.3% of
dogs with 1 to 2 years (9/16), in 53% of dogs with 2 to
5 years (18/34), in 75% in dogs with 5 to 7 years (6/8) and
in 1/1 dog older than 7 years (2011 samples) (Figure 2).
Although there was a linear increase of seropositive
animals with age, this association was not statistically
significant (p > 0.05). The presence of antibodies was
independent of gender (p > 0.05).
Only two samples, collected in each year of the survey,
tested positive for CCoV-RNA, (2010 (1/53, 1.9%) and
2011(1/93,1.1%)).
Table 2 Results of serology investigation in 2011 (Number of positive samples/total of samples analyzed)
2011
Ab classes Ab categories
CPV 100-1000 EU 1000-10000 EU >10000 EU CDV Low titer Medium titer High titer
(IIF 1/20-1/40) (IIF 1/80-1/160) (IIF ≥ 1/320)
n 10/88 29/88 24/88 n 43/88 2/88 0/88
Total 63/88 (71,6%) Total 45/88 (51,1%)
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This study describes for the first time, the shedding of
three common enteric canine viruses, CPV, CDV and
CCoV, in 178 stray dogs from Vila do Maio, Cape Verde
and reports data on CPV and CDV seroprevalence.
Samples were collected in two consecutive years, 2010
and 2011. Similar frequency of positive CPV animals was
found, namely 43.3% in 2010 and 44.1% in 2011, most
probably reflecting the high environmental resistance of
CPV. Viral transmission and spread of CPV can occur
easily, without direct contact between animals. The virus
is shed at high titres in faeces and the excretion period
may last longer, allowing a higher opportunity for con-
tact between the virus and the new hosts. Although
most of the positive dogs did not show signals of diar-
rhoea, recovered animals may also serve as asymptom-
atic reservoirs and shed virus periodically, contributing
for the persistence and continuous circulation of CPV in
the environment, as already reported for cats [15].
Also, the CPV resistance to environmental conditions
may explain the high seroprevalence obtained (71.6%),
similar to that reported in studies conducted with non-
vaccinated dog populations [16,17]. The vast majority of
the positive samples presented a high antibody titer (n =
53) (Table 1 and 2), even though it could not be corre-
lated with hemagglutination inhibition values, the gold
standard assay for titration of CPV antibodies, howeverFigure 1 Seropositivity against CPV, accordxing to age class in 2011 swe did not had the possibility to perform this assay. This
observation suggests the persistence of the virus in the
environment, which is in accordance with the high per-
centage of carrier animals found (44.1%). Within the 56
animals from which both sample types were obtained,
CPV-DNA was detected in 46.6% and seropositivity in
64.3%.
Only 7 of the 26 dogs shedding the virus had no circu-
lating antibodies. It is possible that these animals were at
an early stage of infection. Primary IgMs were not inves-
tigated by the ELISA kit used in this study, which is spe-
cific for IgG detection.
The seroprevalence for CPV was significantly higher in
older animals (p < 0.05), most probably reflecting a high
likelihood of virus exposure over time. Moreover, as
younger dogs are more susceptible to the virus, they can
succumb to the disease and therefore be removed from
the population. Progressive evolution of the CPV-2 led
to the emergence of three antigenic variants, 2a, 2b and
2c, with different properties from the original strain [5].
Monitoring the prevalence of the different CPV in Cape
Verde archipelago would be important, not only to as-
sess the distribution of viral variants in this geographic
location, but also to understand the evolutionary pat-
tern of the virus in this circunscripted population. In
addition, given the high nucleotide substitution rate of
CPV, similar to the RNA viruses [18] and the terrainampling.
Figure 2 Seropositivity against CDV, according to age class in 2011 sampling.
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transportation through people, goods and infected ani-
mals, should be considered.
In 2010 the prevalence of CDV detected by real-time
PCR was 11.3% while in 2011 all the samples were CDV-
RNA negative. Interestingly, in this year, the seropreva-
lence obtained for this virus was 51.1%. As these animals
were non-vaccinated the explanation for the seropositiv-
ity may lie with a previous contact with the virus
through ill animals, which could have occurred the pre-
vious year.
Several factors may explain the absence of CDV shed-
ding in faeces of dogs sampled in 2011. Taking into
account the CDV poor resistance to dry and hot envi-
ronments, it is possible that the virus did not resist the
Cape Verde summer high temperatures, reducing the
opportunity for dogs being exposed to the virus [19,20].
In addition, the high mortality rates caused by CDV con-
tribute to the low virus spread in canine populations
since the animals that succumbed to infection stop shed-
ding. On the other hand, as the animal density of this
city is low compared to larger cities, less contact rates
between animals affect the virus maintenance and spread
[21]. Still, 51.1% of the animals had anti-CDV antibodies.
Comparing the presence of antibodies with the age of
the dogs a linear increase in seroprevalence with age was
found, which may be related to a possible past CDV out-
break in the population.
Although it is not statistically significant, the higher
seroprevalence in older dogs has already been reported
[21]. The presence of CDV antibodies was not associated
with gender.
All CDV seropositive animals (51.1%) showed a pro-
tective antibody titer, according to Twark and Dodds
[22], by establishing a comparison between serumneutralization and IIF assays. Although 96% of these ani-
mals had low antibody titers (Table 1 and 2), Schultz
et al. [23] reported that in actively immunized dogs, ei-
ther naturally or through vaccination, the antibody titer
is not very relevant, provided that is detectable. Never-
theless, and despite the good sensitivity and specificity of
ELISA, it would be advisable to test the samples using
the serum neutralization test to confirm the presence
and titer of neutralizing antibodies, to fully assess the
immune status of these animal populations.
Relating to the genetic variability of CDV, it would in-
teresting to identify the different CDV genotypes in posi-
tive samples, in order to differentiate between vaccine
and field strains, and determine which lineages circulate
on this island.
Regarding CCoV, we found a low prevalence of 1.9%
in 2010 and 1.1% in 2011, which is in agreement with
similar surveys conducted in areas with similar charac-
teristics of Vila do Maio dog population [24,25]. The low
prevalence may indicate a low viral circulation, probably
due to the virus instability in normal environmental con-
ditions and also to the reduced number viral particles in
faeces. As for CPV, dogs recovered from a CCoV infec-
tion may function as asymptomatic reservoirs and shed
the virus periodically, resulting in a persistent and con-
tinued circulation of CCoV in the environment. Avail-
able data concerning the epidemiological mechanisms of
CCoV suggests that the environment provided by ken-
nels can be fundamental in maintaining this infection in
canine populations [25-28].
Seroprevalence against CCoV was not performed due
to the rapid decay of antibodies caused by natural expos-
ure [29]. Moreover the available serological assays are
based on the identification of antibodies against CCoV-
II, and their efficacy is unknown for the detection of
Table 3 Sampling distribution per year of collection
Year
2010 2011
Rectal Swabs (RS) 53 37
Blood - 32
RS + Blood - 56
Total 53 125
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these methods.
Conclusion
The results presented in this study demonstrate that
CPV, CDV and CCoV are circulating in the canine popu-
lation of Vila do Maio, Cape Verde.
The presence of susceptible animals, the high frequency
of infections, the prolonged period of virus shedding and
environmental persistence of these agents, especially of
CPV, contribute to their continuous circulation in this
population. Thus, information regarding the spatial distri-
bution of circulating viruses and the risk factors associated
with infections will definitely facilitate the planning of con-
trol strategies. To our knowledge no vaccination program
is undertaken in this region and its implementation could
contribute to increase the immunity of this population,
reduce viral circulation, and consequently a decrease the
population susceptibility to a future disease outbreaks.
Additionally, the absence of control measures may increase
the risk of pathogen spill over, either for susceptible new-
comers’ hosts or for resident susceptible new hosts as sym-
patric carnivores’ species.
Due to the wide range of CPV and CDV susceptible
hosts, it would be important to identify Maio Island
wildlife, to assess the potential risk of infection of these
species.
Methods
Study population and sampling
Sampling was conducted in Vila do Maio, located on
Maio Island, Cape Verde, under a neutering and health
surveillance program developed by Veterinarians without
Frontiers, Portugal (VSF), in two distinct periods: 2010
with collection of rectal swabs from 53 animals; andTable 4 Nucleotide sequences of the primers and probes used
Primers/Probe CPV (vp1 gene AN AB437433.1) CDV (n ge
Forward 5’→ 3’ GGGCCTGGGAACAGTCTTGACC (900 nM) TGGCACTC







Product 99 bp 100 bp2011, including blood samples (n = 88) and rectal swabs
(n = 93) from 125 animals (Table 3). Biological samples
were stored under refrigeration until processing.
Sample processing
Rectal swabs were homogenized in 300 μl of PBS. After
centrifugation at 10000xg/10 min, the supernatant was
collected and stored at −80°C. Blood samples were cen-
trifuged at 4000xg/10 min to separate plasma from
blood cells. Plasma was stored at −20°C until processing.
PCR assay procedures
For viral nucleic acid extraction, 200 μl of supernatant
from each rectal swab, were processed with the Qiamp
Minelute kit® (Qiagen, Germany) according to the manufac-
turer's instructions, for viral DNA and RNA co-extraction.
Although using a commercial kit for co- extraction of viral
nucleic acids, from a non-recommended biological matrix
may imply a reduced nucleic acid yield, it is sufficient in
their experience [31,32].
Detection of viral nucleic acids using real-time PCR
(qPCR) and real-time rt-PCR (rt qPCR) CPV DNA was
amplified by qPCR using TaqMan® Gene Expression 2×
Master Mix (Applied Biosystems); CDV and CCoV RNA
were amplified by rt-qPCR using the TaqMan® RNA-to-Ct
(TM) 1 step kit in a 20 μl reaction with 50 ng of template.
Primers and TaqMan® probes were calculated using
the Primer designing tool of NCBI (http://www.ncbi.
nlm.nih.gov/tools/primer-blast/). For CPV, primers were
based on the nucleotide sequence of the vp1 gene, avail-
able through its access number (AN) AB437433.1. CDV
primers were chosen within the nucleocapsid gene (AN
JN896987.1) [7] and CCoV primers targeted the highly
conserved 7b gene (AN JQ404410.1) as already described
by [33] (Table 4). A final concentration of 900 nM for the
forward primer, 900 nM of reverse primer and 250 nM of
each TaqMan® probe was used (Table 4).
The amplification was performed in the StepOne Plus
thermocycler (Applied Biosystems) and the cycling condi-
tions comprised an initial denaturation step at 95°C for
10 minutes, followed by 40 cycles at 95°C for 15 seconds
and 1 minute at 60°C. When the template was RNA the
amplification cycle included a reverse transcription step at
48°C for 15 minutes.in qPCR (CPV) and rt-qPCR (CDV; CCoV) assays
ne AN JN896987.1) CCoV (7b gene (AN JQ404410.1)
ATTTTGGACATCAA (900 nM) TGGTCATCGCGCTGTCTACT (900 nM)
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strain (Tetradog®, Merial) were used as positive control.
Regarding CDV, a 287 bp fragment, including the targeted
region was amplified from CDV RNA (Caniffa®, Merial) [7]
and cloned in pGEM® Teasy vector (Promega) according to
the manufactures instructions. The CDV recombinant plas-
mid was used as positive control. A similar approach was
used for CCoV as already described [34].
The assay specificity was confirmed by direct sequen-
cing of the CPV amplicon. For CDV and CCoV sequen-
cing was performed after plasmid cloning. No cross
reactivity was detected between CDV/CCoV/CPV. The
sensitivity of the rt-qPCR/qPCR for all three agents sur-
passed the detection of 10 target copies/μl, assessed by
conversion of the positive control mass (g/μl) in mole-
cules/μl, based on the following formula: number of cop-
ies (molecules/μl) = [mass (g/μl)/(number of base pairs x
bp (660)] x Avogadro's number (6,022 x 1023).
Antibody detection
Antibody (Ab) detection was only performed for 2011
serum samples for CPV and CDV using an indirect
ELISA kit (Ingezim Canine Parvo 15.CPV.K1® and Inge-
zim Moquillo 1.5.CDG.K.1®-Ingenasa), for specific IgG
detection, according to the manufactures instructions.
This method allowed the quantification of the Ab
titer for CPV, using a formula provided by the kit, al-
though it did not specify the correspondence with the
hemagglutination inhibition assay for quantification of
anti-CPV antibodies. The values were organized in
three classes: 1) 100–1000 ELISA Units (EU); 2) 1000–
10000 EU and 3) > 10000 EU.
For CDV the OD values had correspondence with the in-
direct immunofluorescence (IIF) method, and the values
were divided into three categories: 1) low titer (IIF values:
1/20-1/40), 2) medium titer (IIF values: 1/80-1/160) and 3)
high titer (IIF values: ≥ 1/320).
Statistical analysis
A possible association between serological findings and the
age and gender of the animals was determined by chi-
square statistical test (χ2) with IBM SPSS Statistics 19.0
software. A P value <0.05 was considered significant.
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